Subcutaneous recombinant factor IX (BeneFIX™) administration produces therapeutic levels of FIX activity in hemophilia B dogs - Brinkhous, KM; Sigman, JL; Read, MS; Stewart, PF; Bush, L; Bartlett, E; Rup, B; Keith, JC, Jr; Garzone, P; McCarthy, K; Schaub, RG (Blood, 1996)